Position in FATE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$31,596
+$8,900 QoQ
Shares Held
26,330
+13.7% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $506,574,956 across 170 Biotechnology names. FATE ranks #158 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,491 | $108,548,965 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
131,560 | $58,746,801 | |
| 3 | INCY |
Incyte Corp
|
374,280 | $35,227,233 | |
| 4 | EXEL |
Exelixis, Inc.
|
463,825 | $19,893,454 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
64,133 | $12,804,153 | |
| 6 | ALMS |
Alumis Inc.
|
538,733 | $11,868,287 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
164,570 | $11,212,154 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
95,235 | $10,037,769 |
All Filings in FATE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,596 | 26,330 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $22,696 | 23,160 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $54,420 | 43,191 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $24,405 | 21,791 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $57,899 | 73,291 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $530,311 | 321,401 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,248,103 | 356,601 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,168,011 | 356,101 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,812,695 | 383,201 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,094,441 | 560,011 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $413,211 | 194,911 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $315,640 | 66,311 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $911,492 | 159,911 | Shares | Defined | 2023-05-12 | |
| 2022-03-31 | $262,317 | 6,766 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $399,505 | 6,828 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,327,657 | 73,016 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,468,458 | 74,530 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,357,188 | 64,975 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,276,714 | 69,028 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $2,174,567 | 54,405 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,957,900 | 57,065 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,707,037 | 76,859 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||